Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|16|8|602-608

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.16, Iss.8, 2015-10, pp. : 602-608

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Children with Multiple Sclerosis

By Yeh E. Ann  

Pediatric Drugs, Vol. 14, Iss. 3, 2012-06 ,pp. : 165-177

Adis International

Access to resources Recommend Favorite

Management of Secondary-Progressive Multiple Sclerosis

By Gavin Giovannoni  

CNS Drugs, Vol. 18, Iss. 10, 2004-01 ,pp. : 653-669

Adis International

Access to resources Recommend Favorite

Management of Fatigue in Patients with Multiple Sclerosis

By Zifko U.A.  

Drugs, Vol. 64, Iss. 12, 2004-01 ,pp. : 1295-1304

Adis International

Access to resources Recommend Favorite

Pharmacogenomics of Multiple Sclerosis: Current Status and Potential Applications

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 8, Iss. 4, 2010-12 ,pp. : 273-279

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Management of Pain in Patients with Multiple Sclerosis

By Solaro Claudio  

Drugs, Vol. 70, Iss. 10, 2010-07 ,pp. : 1245-1254

Adis International

Access to resources Recommend Favorite